Ontology type: schema:ScholarlyArticle
1976-08
AUTHORSLEONA AMARAL, SEYMOUR WERTHAMER
ABSTRACTTHE successful development and maintenance of a neoplastic malignancy is generally accepted to result from a temporary or lasting suppression of cell-mediated immune mechanisms. Many studies illustrate that whereas lymphocytes of a cancer patient are functionally sound, their participation in cell-mediated immune responses to an anti-genie neoplasm is abrogated by factors present in the plasma1. Among such factors identified are certain plasma proteins whose concentrations are markedly higher in the plasma of the cancer patient2. We have shown that the content of transcortin, the cortisol-binding protein of human plasma, is higher in patients with demonstrable cancer3, and since transcortin inhibits the response of human lymphocytes to phytohaemagglutinin4, a test generally accepted as demonstrative of active cell-mediated potential, we have attempted to study the relationship of such elevated levels of plasma transcortin to breast cancer. More... »
PAGES589
http://scigraph.springernature.com/pub.10.1038/262589a0
DOIhttp://dx.doi.org/10.1038/262589a0
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1008805244
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/8726
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Immunology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adenofibroma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma, Intraductal, Noninfiltrating",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cytosol",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gynecomastia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunity, Cellular",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "T-Lymphocytes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transcortin",
"type": "DefinedTerm"
}
],
"author": [
{
"familyName": "AMARAL",
"givenName": "LEONA",
"type": "Person"
},
{
"familyName": "WERTHAMER",
"givenName": "SEYMOUR",
"id": "sg:person.063777024.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.063777024.27"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1016/0304-4165(74)90226-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007977611"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0304-4165(74)90226-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007977611"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1530/acta.0.0620468",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022315791"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1172/jci108341",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026465860"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0014-2964(75)90072-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036060388"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075218985",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1080143234",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1080339788",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1080871159",
"type": "CreativeWork"
}
],
"datePublished": "1976-08",
"datePublishedReg": "1976-08-01",
"description": "THE successful development and maintenance of a neoplastic malignancy is generally accepted to result from a temporary or lasting suppression of cell-mediated immune mechanisms. Many studies illustrate that whereas lymphocytes of a cancer patient are functionally sound, their participation in cell-mediated immune responses to an anti-genie neoplasm is abrogated by factors present in the plasma1. Among such factors identified are certain plasma proteins whose concentrations are markedly higher in the plasma of the cancer patient2. We have shown that the content of transcortin, the cortisol-binding protein of human plasma, is higher in patients with demonstrable cancer3, and since transcortin inhibits the response of human lymphocytes to phytohaemagglutinin4, a test generally accepted as demonstrative of active cell-mediated potential, we have attempted to study the relationship of such elevated levels of plasma transcortin to breast cancer.",
"genre": "research_article",
"id": "sg:pub.10.1038/262589a0",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1018957",
"issn": [
"0090-0028",
"1476-4687"
],
"name": "Nature",
"type": "Periodical"
},
{
"issueNumber": "5569",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "262"
}
],
"name": "Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity",
"pagination": "589",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"29f3d743534d3540860c2bfd316abb1dc284897fa33d3794b67d23443a69b6b4"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"8726"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"0410462"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/262589a0"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1008805244"
]
}
],
"sameAs": [
"https://doi.org/10.1038/262589a0",
"https://app.dimensions.ai/details/publication/pub.1008805244"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T12:27",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87119_00000000.jsonl",
"type": "ScholarlyArticle",
"url": "https://www.nature.com/articles/262589a0"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/262589a0'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/262589a0'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/262589a0'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/262589a0'
This table displays all metadata directly associated to this object as RDF triples.
138 TRIPLES
21 PREDICATES
49 URIs
33 LITERALS
21 BLANK NODES